BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 24636026)

  • 1. Assessment of total hepatitis C virus (HCV) core protein in HCV-related mixed cryoglobulinemia.
    Russi S; Sansonno D; Mariggiò MA; Vinella A; Pavone F; Lauletta G; Sansonno S; Dammacco F
    Arthritis Res Ther; 2014 Mar; 16(2):R73. PubMed ID: 24636026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recurrent Mixed Cryoglobulinemia Despite Sustained Virologic Response to Treatment: A Case Report.
    Chowdhury R; Tsen A
    Am J Kidney Dis; 2017 Aug; 70(2):301-304. PubMed ID: 28343737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A clinical and virological study of hepatitis C virus-related cryoglobulinemia in Germany.
    Weiner SM; Berg T; Berthold H; Weber S; Peters T; Blum HE; Hopf U; Peter HH
    J Hepatol; 1998 Sep; 29(3):375-84. PubMed ID: 9764983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sustained response to interferon-alpha or to interferon-alpha plus ribavirin in hepatitis C virus-associated symptomatic mixed cryoglobulinaemia.
    Calleja JL; Albillos A; Moreno-Otero R; Rossi I; Cacho G; Domper F; Yebra M; Escartín P
    Aliment Pharmacol Ther; 1999 Sep; 13(9):1179-86. PubMed ID: 10468699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between rheumatoid factor and the immune response against hepatitis C virus in essential mixed cryoglobulinemia.
    Pietrogrande M; Corona M; Milani S; Rosti A; Ramella M; Tordato G
    Clin Exp Rheumatol; 1995; 13 Suppl 13():S109-13. PubMed ID: 8730489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term effect of HCV eradication in patients with mixed cryoglobulinemia: a prospective, controlled, open-label, cohort study.
    Gragnani L; Fognani E; Piluso A; Boldrini B; Urraro T; Fabbrizzi A; Stasi C; Ranieri J; Monti M; Arena U; Iannacone C; Laffi G; Zignego AL;
    Hepatology; 2015 Apr; 61(4):1145-53. PubMed ID: 25431357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Virological and Clinical Response to Interferon-Free Regimens in Patients with HCV-Related Mixed Cryoglobulinemia: Preliminary Results of a Prospective Pilot Study.
    Gragnani L; Piluso A; Urraro T; Fabbrizzi A; Fognani E; Petraccia L; Genovesi A; Giubilei L; Ranieri J; Stasi C; Monti M; Zignego AL
    Curr Drug Targets; 2017; 18(7):772-785. PubMed ID: 26853322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis C virus and its genotypes in patients suffering from chronic hepatitis C with or without a cryoglobulinemia-related syndrome.
    Willems M; Sheng L; Roskams T; Ramdani B; Doutrelepont JM; Nevens F; Durez P; Treille S; Adler M; Desmet V
    J Med Virol; 1994 Nov; 44(3):266-71. PubMed ID: 7531756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis C virus genotype analysis in patients with type II mixed cryoglobulinemia.
    Zignego AL; Ferri C; Giannini C; Monti M; La Civita L; Careccia G; Longombardo G; Lombardini F; Bombardieri S; Gentilini P
    Ann Intern Med; 1996 Jan; 124(1 Pt 1):31-4. PubMed ID: 7503475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiviral therapy of symptomatic HCV-associated mixed cryoglobulinemia: meta-analysis of clinical studies.
    Fabrizi F; Dixit V; Messa P
    J Med Virol; 2013 Jun; 85(6):1019-27. PubMed ID: 23588727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis C virus (HCV) infection and cryoglobulinemia: analysis of whole blood and plasma HCV-RNA concentrations and correlation with liver histology.
    Schmidt WN; Stapleton JT; LaBrecque DR; Mitros FA; Kirby PA; Phillips MJ; Brashear DL
    Hepatology; 2000 Mar; 31(3):737-44. PubMed ID: 10706566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regression of monoclonal B-cell expansion in patients affected by mixed cryoglobulinemia responsive to alpha-interferon therapy.
    Mazzaro C; Franzin F; Tulissi P; Pussini E; Crovatto M; Carniello GS; Efremov DG; Burrone O; Santini G; Pozzato G
    Cancer; 1996 Jun; 77(12):2604-13. PubMed ID: 8640712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The effect of cryoglobulinemia on the antiviral therapy in patients with chronic hepatitis C].
    Fan XH; Wang LF; Liu LC; Yao Y; Shan Y; Lu HY; Wu CH; Xu XY; Wei L
    Zhonghua Gan Zang Bing Za Zhi; 2011 Oct; 19(10):721-5. PubMed ID: 22409840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-enveloped HCV core protein as constitutive antigen of cold-precipitable immune complexes in type II mixed cryoglobulinaemia.
    Sansonno D; Lauletta G; Nisi L; Gatti P; Pesola F; Pansini N; Dammacco F
    Clin Exp Immunol; 2003 Aug; 133(2):275-82. PubMed ID: 12869035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis C virus infection in patients with essential mixed cryoglobulinemia.
    Misiani R; Bellavita P; Fenili D; Borelli G; Marchesi D; Massazza M; Vendramin G; Comotti B; Tanzi E; Scudeller G
    Ann Intern Med; 1992 Oct; 117(7):573-7. PubMed ID: 1326246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct-Acting Antiviral Therapy Restores Immune Tolerance to Patients With Hepatitis C Virus-Induced Cryoglobulinemia Vasculitis.
    Comarmond C; Garrido M; Pol S; Desbois AC; Costopoulos M; Le Garff-Tavernier M; Si Ahmed SN; Alric L; Fontaine H; Bellier B; Maciejewski A; Rosenzwajg M; Klatzmann D; Musset L; Poynard T; Cacoub P; Saadoun D
    Gastroenterology; 2017 Jun; 152(8):2052-2062.e2. PubMed ID: 28274850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transfusion-associated TT virus co-infection in patients with hepatitis C virus is associated with type II mixed cryoglobulinemia but not with B-cell non-Hodgkin lymphoma.
    Cacoub P; Rosenthal E; Gerolami V; Hausfater P; Ghillani P; Sterkers Y; Thibault V; Khiri H; Piette JC; Halfon P
    Clin Microbiol Infect; 2003 Jan; 9(1):39-44. PubMed ID: 12691541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GB virus C infection in patients with type II mixed cryoglobulinemia.
    Misiani R; Mantero G; Bellavita P; Mori L; Vicari O; Marchesi D; Primi D
    Ann Intern Med; 1997 Nov; 127(10):891-4. PubMed ID: 9382367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PEGylated interferon alfa-2b and ribavirin treatment in patients with hepatitis C virus-related systemic vasculitis.
    Cacoub P; Saadoun D; Limal N; Sene D; Lidove O; Piette JC
    Arthritis Rheum; 2005 Mar; 52(3):911-5. PubMed ID: 15751068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cryoglobulinemia in chronic hepatitis C virus infection: prevalence, clinical manifestations, response to interferon treatment and analysis of cryoprecipitates.
    Hartmann H; Schott P; Polzien F; Mihm S; Uy A; Kaboth U; Pardowitz I; Ramadori G
    Z Gastroenterol; 1995 Nov; 33(11):643-50. PubMed ID: 8600660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.